Skip to main content
. 2023 Mar 27;2023(3):CD009885. doi: 10.1002/14651858.CD009885.pub3
Summary (participants) Number of participants screened
Number of participants included
Participants were randomly assigned to 1 of X possible drug condition orders
Number of participants followed up
Number of withdrawals
Diagnostic and Statistical Manual of Mental Disorders (DSM) or International Classification of Diseases (ICD) diagnosis of attention deficit hyperactivity disorder (ADHD) (combined (%), hyperactive‐impulsive (%), inattentive (%))
Age (years) (mean, range)
IQ (mean, range)
Sex (male, female)
Methylphenidate naive (%/number)
Ethnicity (white (%), African‐american (%), Asian (%), Hispanic (%), other (%))
Country
Comorbidity (type %)
Comedication (no/yes)
Sociodemographics (e.g. double‐ or single‐parent family, low, middle or upper class)
Inclusion criteria
Exclusion criteria